Want to join the conversation?
$AGN, a global pharmaceutical company, announces the launch of a generic version of Janssen's INVEGA (paliperidone extended-release tablets) in the U.S. $AGN is the first to receive the FDA approval for generic version of INVEGA. INVEGA extended-release tablets are used for the treatment of schizophrenia in adults and adolescents.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!